MIT 1000 System Enters Final AOAC Performance Test Method Certification Process

SAN CLEMENTE, CA--(Marketwire - February 9, 2009) - Micro Imaging Technology, Inc. (OTCBB: MMTC) announces that its product, the MIT 1000 Rapid Microbial Identification System, has entered the final stage of the Association of Advanced Communities Research Institute (AOAC RI) Performance Test Method certification process that is a pre-requisite for sales into the U.S. and most international food protection markets. Each Performance Test Method is independently tested, rigorously evaluated, and thoroughly analyzed by the AOAC RI and its expert reviewers.

The identification (ID) process of the MIT 1000 is very different from conventional methods and required several months of education and discussions with the AOAC RI to create a suitable test protocol. Recently, the test protocol was completed and is designed to test the MIT 1000 System for accuracy, repeatability and robustness that will provide the User with the confidence that our leading edge technology performs equal to or better than any conventional microbiology ID method.

The certification process is separated into two major segments. The first consists of accuracy and repeatability performance of MIT's test method and is assigned to two laboratories: (1) MIT's laboratory in San Clemente, CA and (2) the USDA's Agricultural Research Service (USDA - ARS) laboratory In Pennsylvania. The second test segment determines the robustness of the System's performance to typical User variations of our recommended ID test procedure. The AOAC RI's initial Performance Test Method certification will be for the ID of Listeria, closely followed by E.coli and Salmonella -- which completes the list of the most ubiquitous food pathogens.

The MIT 1000 System has been reviewed by several potential buyers and distribution partners in the food processing and clinical diagnostic industries. Following successful completion of the Performance Test Method certification, several major worldwide companies with multiple system requirements will comprehensively evaluate MIT 1000 Systems for purchase.

During 2008, the MIT 1000 System was employed by two independent laboratories, one of which was the USDA - ARS, and achieved excellent results, with over 90 percent accuracy. MIT's technical team has made further enhancements to the System's ID software algorithms and now expects performance levels at or near 100 percent accuracy.

"The food industry is our initial targeted market where over $3 billion is spent in rapid identification testing annually and rising at 10 percent per year -- which should accelerate after all the recent food product contaminations. We are pleased with the development progress made in 2008 and strongly believe we will achieve AOAC RI performance test method certification this quarter," stated Michael Brennan, MIT's Chairman. Mr. Brennan further stated, "MIT's technology is totally GREEN and does not require the use of reagents, chemicals or DNA processing to perform an ID test, only clean water, thus yielding a per test cost of pennies. This benefit, along with the System's ability to complete an ID test in less than 5 minutes, has generated high interest in potential customers. We are anxious to aggressively begin marketing this System."

About AOAC International and AOAC Research Institute:

AOAC International is a globally recognized, independent, not-for-profit association founded in 1884. To attain its vision of "worldwide confidence in analytical results," AOAC serves communities of the analytical sciences by providing the tools and processes necessary to develop voluntary consensus standards or technical standards through stakeholder consensus and working groups in which the fit-for-purpose and method performance criteria are established and fully documented.

The AOAC Research Institute is part of AOAC International and maintains an up-to-the minute list of Performance Tested Methods. Performance Tested Methods have been independently tested, rigorously evaluated, and thoroughly reviewed by the AOAC Research Institute and its expert reviewers.

About Micro Imaging Technology:

The Company has developed and patented a technology for rapid microbe detection and identification. This System measures scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. The MIT System is non-biological and does not rely on biological agents, conventional chemical processing, fluorescent tags, gas chromatography or DNA analysis.

MIT has demonstrated the ability to detect and identify, within several minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, and other pathogenic bacteria. MIT recently performed over 300 tests for the identification of the aforementioned contaminants and scored 95% accuracy. The System can currently identify 23 species of bacteria and its ID capability is easily expanded.

The identification process has been verified by North American Science Associates, Inc. (NAMSA), an independent, internationally recognized biological testing laboratory. The NAMSA Test Report, in the Company's opinion, demonstrated the accuracy, speed and efficiency of the MIT System over conventional processes and is available from the Company.

This release contains statements that are forward-looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.

Contact Information: CONTACT: Michael Brennan Chairman Email: Telephone: (805) 557-0614